{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:27:29Z","timestamp":1786721249338,"version":"build-2736575974"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Logic Co., Ltd, Hamamatsu, Shizuoka, Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06694-6","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:30:07Z","timestamp":1786717807000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deep learning-based automated identification of papillary bladder cancer from endoscopic still images using SE-ResNeXt-50"],"prefix":"10.1007","volume":"44","author":[{"given":"Yuto","family":"Matsushita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyohei","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayana","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Motoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Inamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"issue":"1","key":"6694_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.euf.2019.04.002","volume":"7","author":"S Ourfali","year":"2021","unstructured":"Ourfali S, Ohannessian R, Fassi-Fehri H, Pages A, Badet L, Colombel M (2021) Recurrence rate and cost consequence of the shortage of Bacillus Calmette-Guerin Connaught strain for bladder cancer patients. Eur Urol Focus 7(1):111\u2013116","journal-title":"Eur Urol Focus"},{"issue":"1","key":"6694_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40425-017-0271-0","volume":"5","author":"AM Kamat","year":"2017","unstructured":"Kamat AM, Bellmunt J, Galsky MD, Konety BR, Lamm DL, Langham D et al (2017) Society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of bladder carcinoma. J Immunother Cancer 5(1):68","journal-title":"J Immunother Cancer"},{"issue":"33","key":"6694_CR3","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1200\/JCO-25-01651","volume":"43","author":"S Daneshmand","year":"2025","unstructured":"Daneshmand S, Van der Heijden MS, Jacob JM, Guerrero-Ramos F, Bogemann M, Simone G et al (2025) TAR-200 for Bacillus Calmette-Guerin-unresponsive high-risk non-muscle-invasive bladder cancer: results from the phase IIb SunRISe-1 study. J Clin Oncol 43(33):3578\u20133588","journal-title":"J Clin Oncol"},{"issue":"4","key":"6694_CR4","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.euo.2025.06.003","volume":"8","author":"PE Gabriel","year":"2025","unstructured":"Gabriel PE, Roumiguie M, Marcq G, Allory Y, Audenet F, Bajeot AS et al (2025) The evolving landscape of systemic immunotherapy for Bacillus Calmette-Guerin-naive high-risk non-muscle-invasive bladder cancer: at the edge of a Tsunami? Eur Urol Oncol 8(4):1174\u20131181","journal-title":"Eur Urol Oncol"},{"issue":"7","key":"6694_CR5","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1158\/1078-0432.CCR-24-2812","volume":"31","author":"L Colbert","year":"2025","unstructured":"Colbert L, Jia Y, Sharma A, Hu J, Xu Z, Suzman DL et al (2025) FDA approval summary: Nadofaragene Firadenovec-vncg for Bacillus Calmette-Guerin-unresponsive non-muscle-invasive bladder cancer. Clin Cancer Res 31(7):1182\u20131185","journal-title":"Clin Cancer Res"},{"issue":"18","key":"6694_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71243","volume":"14","author":"X Huang","year":"2025","unstructured":"Huang X, Wang X, He Z, Huang Y, Hu B, Chen W et al (2025) Mechanisms, clinical trials, and new treatments for BCG-unresponsive in nonmuscle invasive bladder cancer. Cancer Med 14(18):e71243","journal-title":"Cancer Med"},{"issue":"6","key":"6694_CR7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.eururo.2023.08.004","volume":"84","author":"PC Black","year":"2023","unstructured":"Black PC, Tangen CM, Singh P, McConkey DJ, Lucia MS, Lowrance WT et al (2023) Phase 2 trial of atezolizumab in Bacillus Calmette-Guerin-unresponsive high-risk non-muscle-invasive bladder cancer: SWOG S1605. Eur Urol 84(6):536\u2013544","journal-title":"Eur Urol"},{"issue":"4","key":"6694_CR8","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3390\/cancers16040810","volume":"16","author":"G Feretzakis","year":"2024","unstructured":"Feretzakis G, Juliebo-Jones P, Tsaturyan A, Sener TE, Verykios VS, Karapiperis D et al (2024) Emerging trends in AI and radiomics for bladder, kidney, and prostate cancer: a critical review. Cancers 16(4):810","journal-title":"Cancers"},{"key":"6694_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1591742","volume":"15","author":"CG Lisson","year":"2025","unstructured":"Lisson CG, Gallee L, Muller K, Manoj S, Stockl H, Zengerling F et al (2025) Machine learning-based radiomics for bladder cancer staging: evaluating the role of imaging timing in differentiating T2 from T3 disease. Front Oncol 15:1591742","journal-title":"Front Oncol"},{"key":"6694_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae030","author":"F Mehmood","year":"2024","unstructured":"Mehmood F, Arshad S, Shoaib M (2024) ADH-enhancer: an attention-based deep hybrid framework for enhancer identification and strength prediction. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbae030","journal-title":"Brief Bioinform"},{"key":"6694_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14232637","author":"M Yildirim","year":"2024","unstructured":"Yildirim M (2024) Content-based image retrieval and image classification system for early prediction of bladder cancer. Diagnostics (Basel). https:\/\/doi.org\/10.3390\/diagnostics14232637","journal-title":"Diagnostics (Basel)"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06694-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06694-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06694-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:30:07Z","timestamp":1786717807000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06694-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6694"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06694-6","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"17 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ayumi Tamura and Tatsuya Masuda are full-time employees of Logic Corporation. Teruo Inamoto received institutional research funding from Logic Corporation paid directly to Hamamatsu University School of Medicine to cover computational equipment leasing costs; he received zero personal financial compensation, consulting fees, or lecture honoraria. The remaining authors declare no competing financial or non-financial interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"566"}}